A novel vaccine that targets inflamed brain cells associated with Alzheimer's disease may hold the key to potentially preventing or modifying the course of the disease, according to preliminary research presented at the American ...
Jul 30, 2023
3
17
Public confidence in vaccines has plunged across sub-Saharan Africa since the COVID-19 pandemic, according to a study of 17,000 people, across eight countries, published today in the journal Human Vaccines & Immunotherapeutics.
Jun 8, 2023
1
85
Researchers from the University of Pittsburgh and the National Institutes of Health (NIH) Vaccine Research Center have developed an improved way to test potential vaccines against bird flu. The report was published this week ...
Sep 29, 2023
0
29
Adjuvants—ingredients that help boost the immune response in vaccines—have been used in vaccines for decades. But inducing a stronger immune response can result in more unwanted side effects, like swelling at the injection ...
Apr 5, 2023
0
35
The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to mutations that could make the vaccine less effective over time. Focusing on the T-cell instead, ...
Apr 13, 2023
0
87
A study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.
May 3, 2024
0
56
After helping to develop and test new mRNA technologies for COVID-19 vaccines, University of Maryland School of Medicine (UMSOM) researchers and scientists are turning their attention to utilizing this innovative technology ...
Apr 7, 2023
1
72
An experimental vaccine against human papillomavirus—HPV—appears to be safe, and most importantly, benefits patients who develop a rare airway cancer that manifests as recurrent obstructive growths requiring dozens, sometimes, ...
Since September, 2022, bivalent mRNA vaccines—which contain elements from both the original wild type COVID strain and an updated component from the omicron strain—have replaced older style monovalent boosters in the ...
Apr 13, 2023
0
39
A major clinical trial has found that an additional COVID-19 vaccine dose led to the majority of clinically extremely vulnerable people mounting defensive antibodies against COVID-19.
May 8, 2024
0
89
